Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom (Q45747974)
scientific article published in September 1999
Language:
(P31) (Q13442814)
(P50) (Q40087357)
(Q42249738)
(P304) 695-701
(P407) (Q1860)
(P433) 3
(P478) 180
(P577) Wednesday, September 1, 1999
(P921) (Q418594)
(Q6946)
(P1433) (Q4051141)
(P1476) "Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom" (language: en)
(P2093) Feinberg JE
Grywacz M
Knight S
Griffiths PD
other details
description scientific article published in September 1999

External Links